Etoiles inactivesEtoiles inactivesEtoiles inactivesEtoiles inactivesEtoiles inactives
 

UFR des Sciences Pharmaceutiques de Lille

 

Nom : MILLET

Prénom : Régis

Contact : Cette adresse e-mail est protégée contre les robots spammeurs. Vous devez activer le JavaScript pour la visualiser.

 

Equipe de recherche

  • Intitulé : LIRIC Equipe : « therapeutic innovation targeting inflammation »
  • Numéro : LIRIC  UMR995 – Equipe 5
  • Thématiques : Inflammation et cancer

Mots-clés : Maladie de Crohn, cannabinoïdes, ischémie reperfusion,  NOD1, dormance tumorale, PD-L1/PD1.

 

Principales publications

  1. R. Millet, J. Domarkas, R. Houssin, P. Gilleron, J.-F. Goossens, P. Chavatte, C. Logé, N. Pommery, J. Pommery, J.-P. Hénichart. Potent and selective farnesyltransferase inhibitors. J. Med. Chem. (2004) 47, 6812-6820. doi: 10.1021/jm030502y.
  2. R. Millet, S. Urig, J. Jacob, E. Amtmann, J.-P. Moulinoux, S. Gromer, K. Becker, E. Davioud-Charvet. Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diaminedichloro-platinum complexes as bitopic and irreversible inhibitors of large thioredoxin reductase. J. Med. Chem. (2005) 48, 7024-7039. doi: 10.1021/jm050256l.
  3. J. El Bakali, G.G. Muccioli, N. Renault, D. Pradal, M. Body-malapel, M. Djouina, L. Hamtiaux, V. Andrzejak, P. Chavatte, P. Desreumeaux, D.M. Lambert, R. Millet. 4-Oxo-1,4-dihydropyridines as selective CB2 receptor ligands: Structural insights into the design of a novel inverse agonist series. J. Med. Chem. (2010) 53, 7918-7931. doi: 10.1021/jm100286k.
  4. N. Wlodarczyk. D. Ryckewaert, P. Gilleron, A. Lemoine, A. Farce, P. Chavatte, J. Dubois, N. Pommery, J.P. Hénichart, C. Furman, R. Millet. Design, synthesis of novel farnesyltransferase inhibitors with 1,4-diazepane scaffold as novels microtubule-destabilizing agent in PC3 cells. J. Med. Chem. (2011) 54, 1178-1190. doi : 10.1021/jm101067y
  5. J. El Bakali, P. Gilleron, M. Body-Malapel, M. Roxane, G.G. Muccioli, M. Djouina,  A. Barczyk, F. Klupsch,  V. Andrzejak-Lucas, E. Lipka, C. Furman, D. M. Lambert, P. Chavatte, P. Desreumaux, R. Millet. 4-Oxo-1,4-dihydropyridines as selective CB2 cannabinoid receptor ligands. Toward new therapeutic agents in the treatment of colitis. J. Med. Chem. (2012) 55, 8948-52. doi: 10.1021/jm3008568.

 afect logo